Accretion Nutraveda Ipo
Accretion Nutraveda IPO Review & Key Points
Review: Neutral
IPO Lead Managers aka Merchant Bankers
Sobhagya Capital Options Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,32,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 5,46,000 Shares | 28.44% |
| QIB (Ex. Anchor) | 3,62,000 Shares | 18.85% |
| NII Shares Offered | 2,76,000 Shares | 14.37% |
| Retail Shares Offered | 6,40,000 Shares | 33.33% |
| Anchor Bidding Date | January 27, 2026 |
| Anchor Investors List | |
| Shares Offered | 5,46,000 Shares |
| Anchor Size | 7.04 Cr. |
| lock-in period end date 50% shares (30 Days) | March 4, 2026 |
| lock-in period end date 50% shares (90 Days) | May 3, 2026 |
| IPO Open Date: | January 28, 2026 |
| IPO Close Date: | January 30, 2026 |
| Basis of Allotment: | February 2, 2026 |
| Refunds: | February 3, 2026 |
| Credit to Demat Account: | February 3, 2026 |
| IPO Listing Date: | February 4, 2026 |
| IPO Bidding Cut-off Time: | January 30, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 53,20,000 | 100% |
| Promoter Holding Post Issue | 72,40,000 | 73.48% |
| Purpose | Crores |
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 |
| Funding working capital requirements of our company | ₹5.50 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹3.07 | ₹2.78 | ₹0.28 | ₹4.06 |
| 2024 | ₹5.20 | ₹4.28 | ₹0.82 | ₹4.64 |
| 2025 | ₹16.06 | ₹12.87 | ₹2.61 | ₹10.86 |
| Sep 2025 | ₹14.07 | ₹11.20 | ₹2.33 | ₹16.35 |
| KPI | Values |
| ROE: | 81.22% |
| ROCE: | 36.98% |
| EBITDA Margin: | 22.79% |
| PAT Margin: | 16.33% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹7.19 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 48.85% |
| Net Asset Value (NAV): | ₹14.72 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 Cr. |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 Cr. |
| IPO Open Date | January 28, 2026 |
| IPO Close Date | January 30, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹122 to ₹129 Per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |